Isracann Biosciences Inc. (TSE:IPOT) has released an update.
Isracann Biosciences Inc. has announced immediate management changes with the resignation of directors Sean Bromley, Yana Popova, Desmond Balakrishnan, and George Vrabec, as well as officers Popova and Matthew Chatterton. The company expressed gratitude for their contributions and best wishes for their future endeavors. Isracann focuses on developing natural health products, targeting the Israeli and Canadian markets.
For further insights into TSE:IPOT stock, check out TipRanks’ Stock Analysis page.
